Literature DB >> 15920012

Inhibition of EBF function by active Notch signaling reveals a novel regulatory pathway in early B-cell development.

Emma M K Smith1, Peter Akerblad, Tom Kadesch, Håkan Axelson, Mikael Sigvardsson.   

Abstract

The Notch signaling pathway is involved in several lineage commitment and differentiation events. One of these is fate determination of the common lymphoid progenitor, promoting T-cell development at the expense of B-cell differentiation. It has been suggested that this process relies on Notch's ability to inhibit E proteins, which are crucial for early B-cell development. Here, we report that Notch signaling also modulates the function of the transcription factor, early B-cell factor (EBF). Transient transfection of intracellular Notch1 (Notch1-IC) into a pre-B cell line resulted in the down-regulation of EBF-regulated promoters and diminished the capacity of EBF to activate these promoters in an epithelial cell line. This correlated with a reduction in the ability of EBF to bind DNA. Ligand-induced stimulation of endogenous Notch receptors with Delta4 mimicked the activity of Notch1-IC toward EBF. These data suggest that Notch signaling may affect B-versus T-lineage commitment by the targeting of both EBF and E2A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920012     DOI: 10.1182/blood-2004-12-4744

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.

Authors:  Christoph Renné; Jose Ignacio Martin-Subero; Maren Eickernjäger; Martin-Leo Hansmann; Ralf Küppers; Reiner Siebert; Andreas Bräuninger
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

2.  The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program.

Authors:  Ari Itoh-Nakadai; Reina Hikota; Akihiko Muto; Kohei Kometani; Miki Watanabe-Matsui; Yuki Sato; Masahiro Kobayashi; Atsushi Nakamura; Yuichi Miura; Yoko Yano; Satoshi Tashiro; Jiying Sun; Tomokatsu Ikawa; Kyoko Ochiai; Tomohiro Kurosaki; Kazuhiko Igarashi
Journal:  Nat Immunol       Date:  2014-10-26       Impact factor: 25.606

Review 3.  Eliciting the T cell fate with Notch.

Authors:  Dil Afroz Sultana; J Jeremiah Bell; Daniel A Zlotoff; Maria Elena De Obaldia; Avinash Bhandoola
Journal:  Semin Immunol       Date:  2010-06-02       Impact factor: 11.130

Review 4.  Hematopoiesis.

Authors:  Michael A Rieger; Timm Schroeder
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005

Review 5.  T cell lineage commitment: identity and renunciation.

Authors:  Ellen V Rothenberg
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

6.  Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes.

Authors:  Lei Nie; Ying Zhao; Wei Wu; Yuan-Zheng Yang; Hong-Cheng Wang; Xiao-Hong Sun
Journal:  Cell Res       Date:  2010-11-30       Impact factor: 25.617

7.  Single-cell analysis of early B-lymphocyte development suggests independent regulation of lineage specification and commitment in vivo.

Authors:  Sasan Zandi; Josefine Ahsberg; Panagiotis Tsapogas; Jenny Stjernberg; Hong Qian; Mikael Sigvardsson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

8.  Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.

Authors:  Leah J Anderson; Richard Longnecker
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

9.  Retroviral insertions in the VISION database identify molecular pathways in mouse lymphoid leukemia and lymphoma.

Authors:  Keith C Weiser; Bin Liu; Gwenn M Hansen; Darlene Skapura; Kathryn E Hentges; Sujatha Yarlagadda; Herbert C Morse Iii; Monica J Justice
Journal:  Mamm Genome       Date:  2007-10-10       Impact factor: 2.957

Review 10.  Early B cell factor: Regulator of B lineage specification and commitment.

Authors:  Kara Lukin; Scott Fields; Jacqueline Hartley; James Hagman
Journal:  Semin Immunol       Date:  2008-08-22       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.